Hospital Mortality from Myocardial Infarction in Latin America and the Caribbean: Systematic Review and Meta-Analysis

Leonardo Alves1,2, Patrícia K Ziegelmann1, Victor Ribeiro2

  • 1Programa de Pós-Graduação em Cardiologia, Universidade Federal do Rio Grande do Sul, Porto Alegre, RS - Brasil.

Insights

In-hospital mortality for ST-elevation myocardial infarction (STEMI) in Latin America was 9.9%, with higher rates linked to less reperfusion therapy. Non-ST-elevation myocardial infarction (NSTEMI) mortality was 6.3%.

Area of Science:

  • Cardiology
  • Public Health
  • Epidemiology

Background:

  • Cardiovascular diseases are a leading cause of death globally, particularly in low- and middle-income countries.
  • Myocardial infarction (MI) represents a significant life-threatening condition within cardiovascular diseases.
  • This study focuses on in-hospital mortality for ST-elevation MI (STEMI) and non-ST-elevation MI (NSTEMI) in Latin America and the Caribbean.

Approach:

  • A systematic literature search was conducted in electronic bibliographic databases.
  • Meta-analysis of cohort studies reporting in-hospital mortality for STEMI and NSTEMI from 2000 onwards.
  • Statistical significance was determined using a p-value < 0.05.

Key Points:

  • Pooled in-hospital mortality for STEMI was 9.9% (95% CI: 9.1 - 10.7), with significant heterogeneity.
  • Higher rates of reperfusion therapy correlated with lower STEMI in-hospital mortality (p<0.001).
  • STEMI mortality was higher in the first decade (2000s) compared to the second (p=0.047).
  • Pooled in-hospital mortality for NSTEMI was 6.3% (95% CI: 5.4 - 7.4) with no significant heterogeneity.

Conclusions:

  • STEMI in-hospital mortality in Latin America and the Caribbean is high compared to high-income countries.
  • Increased use of reperfusion therapy is crucial for improving STEMI outcomes.
  • NSTEMI in-hospital mortality was comparable to high-income countries, though based on limited data from few countries.
Abstract

Related Concept Videos

Acute Coronary Syndrome IV: Interprofessional Care01:28

Acute Coronary Syndrome IV: Interprofessional Care

IntroductionThe management of Acute Coronary Syndrome (ACS) aims to minimize myocardial damage, preserve myocardial function, and prevent complications.Initial ManagementInpatient management involves continuous cardiac monitoring, preferably in an ICU, focusing on blood pressure, serum sodium, potassium, and creatinine levels, and urine output. Ongoing pharmacologic management is crucial for stabilizing the patient.Supplemental Oxygen: Administer supplemental oxygen if oxygen saturation is...
20
Acute Coronary Syndrome III: Diagnostic Studies01:30

Acute Coronary Syndrome III: Diagnostic Studies

Diagnosing acute coronary syndrome or ACS begins with a thorough patient history. Notable symptoms include central, crushing chest pain radiating to the left arm, neck, jaw, or back, along with shortness of breath, sweating (diaphoresis), nausea, vomiting, dizziness, and palpitations.It is crucial to note any history of cardiac illnesses and assess risk factors, including age, gender, smoking, hypertension, diabetes, hyperlipidemia, and a sedentary lifestyle.During physical examination, vital...
20
Angina IV: Management01:26

Angina IV: Management

IntroductionThe management of angina requires a comprehensive approach that includes pharmacological therapies, medical procedures, and lifestyle modifications.Pharmacological TherapiesAntiplatelet agents, such as aspirin, clopidogrel, prasugrel, and ticagrelor, play a pivotal role in preventing thrombus formation in patients with angina. These medications inhibit platelet aggregation and reduce the likelihood of myocardial infarction and other cardiovascular events.Anticoagulants, including...
15
Ischemic Heart Disease: Overview01:17

Ischemic Heart Disease: Overview

Ischemic heart disease occurs when the heart's blood supply dwindles, causing an ominous lack of oxygen and nutrients. This deficiency, stemming from reduced or obstructed blood flow, spells danger, leading to heart muscle damage and dysfunction.
Atherosclerosis, the primary malefactor, orchestrates this dangerous condition. It manifests as the accumulation of fatty deposits, akin to insidious plaques, within arterial walls. As time elapses, these plaques metamorphose, hardening and...
1.4K
Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations01:19

Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations

The pathophysiology of Acute Coronary Syndrome [ACD] involves several key processes:The main underlying cause of ACD is atherosclerosis, a chronic inflammatory disease characterized by the buildup of lipid-laden plaques within the coronary arteries.As the atherosclerotic plaque grows in the coronary artery, it may become unstable due to the formation of a lipid-rich core and a thin fibrous cap. Inflammatory cells within the plaque, such as macrophages, secrete enzymes that degrade the...
34
Acute Coronary Syndrome I: Introduction01:30

Acute Coronary Syndrome I: Introduction

Acute Coronary Syndrome (ACS) encompasses a spectrum of heart conditions caused by sudden obstruction of coronary arteries, typically resulting from the rupture of an atherosclerotic plaque and subsequent thrombus (blood clot) formation. This obstruction can lead to partial or complete blockage of blood flow, causing varying degrees of myocardial ischemia or infarction.ACS includes the following clinical entities:Unstable Angina (UA)Non-ST-Elevation Myocardial Infarction (NSTEMI)ST-Elevation...
56